Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (nuvaring®)

51Citations
Citations of this article
97Readers
Mendeley users who have this article in their library.

Abstract

The contraceptive vaginal ring is a novel contraceptive method that offers unique advantages. Intravaginal delivery of both estrogen and progesterone allows continuous release of medication, resulting in lower systemic levels. The use of long-term combined hormonal contraception enables improved cycle control compared with progesterone-only methods. The indications and usage of the NuvaRing® are described along with the efficacy, tolerability, and safety. Overall, the contraceptive vaginal ring appears to be very effective, with a favorable side-effect profile, and is highly acceptable to most patients. © 2010 Wieder and Pattimakiel, publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Wieder, D. R., & Pattimakiel, L. (2010). Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (nuvaring®). International Journal of Women’s Health, 2(1), 401–409. https://doi.org/10.2147/IJWH.S6162

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free